Managing disruptive behaviour in autism-spectrum disorder with guanfacine.
作者信息
Propper Lukas
机构信息
From the IWK Health Centre, Department of Psychiatry and Dalhousie University, Department of Psychiatry, Halifax, NS, Canada.
出版信息
J Psychiatry Neurosci. 2018 Aug;43(5):359-360. doi: 10.1503/jpn.180039.
Abstract
摘要
相似文献
1
Managing disruptive behaviour in autism-spectrum disorder with guanfacine.
J Psychiatry Neurosci. 2018 Aug;43(5):359-360. doi: 10.1503/jpn.180039.
2
Pediatric Psychopharmacology Trials: Beyond Efficacy.
Am J Psychiatry. 2015 Dec;172(12):1171-2. doi: 10.1176/appi.ajp.2015.15101269.
3
Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
Am J Psychiatry. 2015 Dec;172(12):1197-206. doi: 10.1176/appi.ajp.2015.15010055. Epub 2015 Aug 28.
4
Guanfacine as a Facilitator of Recovery from Conversion Disorder in a Young Girl.
J Child Adolesc Psychopharmacol. 2018 Oct;28(8):571-575. doi: 10.1089/cap.2018.29154.bjc.
5
Neurocognitive dysfunction and pharmacological intervention using guanfacine in a rhesus macaque model of self-injurious behavior.
Transl Psychiatry. 2015 May 19;5(5):e567. doi: 10.1038/tp.2015.61.
6
Guanfacine extended-release (intuniv) for ADHD.
Med Lett Drugs Ther. 2010 Oct 18;52(1349):82-3.
7
Two case reports of extended-release guanfacine overdose in children.
Pediatr Int. 2023 Jan;65(1):e15424. doi: 10.1111/ped.15424.
8
Efficacy and Safety of Alpha-2 Agonists in Autism Spectrum Disorder: A Systematic Review.
Adv Ther. 2024 Nov;41(11):4299-4311. doi: 10.1007/s12325-024-02980-0. Epub 2024 Sep 13.
9
Guanfacine extended release in two patients with pervasive developmental disorders.
J Child Adolesc Psychopharmacol. 2011 Jun;21(3):287-90. doi: 10.1089/cap.2010.0057.
10
Exploring the neurocognitive correlates of challenging behaviours in young people with autism spectrum disorder.
Autism. 2019 Jul;23(5):1152-1164. doi: 10.1177/1362361318769176. Epub 2018 Oct 5.
引用本文的文献
1
Efficacy of Guanfacine for Self-injurious and Aggressive Behaviors through the Reduction of Impulsivity in Borderline Personality Disorder: Two Case Reports and a Literature Review.
Clin Psychopharmacol Neurosci. 2025 Aug 31;23(3):520-525. doi: 10.9758/cpn.24.1263. Epub 2025 Mar 17.
2
Alpha-2 Agonists in Children and Adolescents With Post-traumatic Stress Disorder: A Systematic Review.
Cureus. 2024 Jan 26;16(1):e53009. doi: 10.7759/cureus.53009. eCollection 2024 Jan.
3
Updates in the Assessment and Management of Agitation.
Focus (Am Psychiatr Publ). 2023 Jan;21(1):35-45. doi: 10.1176/appi.focus.20220064. Epub 2023 Jan 16.
4
Sleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics.
Neurobiol Sleep Circadian Rhythms. 2023 Apr 26;14:100095. doi: 10.1016/j.nbscr.2023.100095. eCollection 2023 May.
5
Two Sisters From Qatar With TUSC3 Genetic Mutation: Psychiatric Considerations.
Cureus. 2021 Aug 31;13(8):e17616. doi: 10.7759/cureus.17616. eCollection 2021 Aug.
6
Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.
Neurobiol Learn Mem. 2020 Dec;176:107327. doi: 10.1016/j.nlm.2020.107327. Epub 2020 Oct 17.
本文引用的文献
1
A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures.
Neuropsychopharmacology. 2018 Jul;43(8):1772-1778. doi: 10.1038/s41386-018-0039-3. Epub 2018 Feb 27.
2
Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
Am J Psychiatry. 2015 Dec;172(12):1197-206. doi: 10.1176/appi.ajp.2015.15010055. Epub 2015 Aug 28.
3
Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial.
JAMA. 2015 Apr 21;313(15):1524-33. doi: 10.1001/jama.2015.3150.
4
The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?
Front Hum Neurosci. 2014 Apr 29;8:268. doi: 10.3389/fnhum.2014.00268. eCollection 2014.
5
Impact of ADHD symptoms on autism spectrum disorder symptom severity.
Res Dev Disabil. 2013 Oct;34(10):3545-52. doi: 10.1016/j.ridd.2013.07.028. Epub 2013 Aug 22.
6
A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):74-85.e2. doi: 10.1016/j.jaac.2011.10.012. Epub 2011 Nov 25.
7
Aggression in children and adolescents with ASD: prevalence and risk factors.
J Autism Dev Disord. 2011 Jul;41(7):926-37. doi: 10.1007/s10803-010-1118-4.
8
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.
CNS Drugs. 2010 Sep;24(9):755-68. doi: 10.2165/11537790-000000000-00000.
9
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Pediatrics. 2009 Dec;124(6):1533-40. doi: 10.1542/peds.2008-3782.
10
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1110-1119. doi: 10.1097/CHI.0b013e3181b76658.
Zotero 插件